HLA-B1502 is strongly associated with SJS and TEN in response to carbamazepine treatment, especially in certain Asian populations. Unlike HLA-A3101, which has a broader hypersensitivity profile, HLA-B1502’s risk is more specifically focused on severe cutaneous reactions.
Subscribe to our newsletter.